Healthcare provider profile · identity verified

Jovite Nguembou, NP

Nurse Practitioner · NEW YORK, NY · NPI 1114446077

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	400	169
Amlodipine Besylate	Amlodipine Besylate	360	148
Levothyroxine Sodium	Levothyroxine Sodium	243	133
Gabapentin	Gabapentin	234	108
Metformin Hcl	Metformin Hcl	228	95
Furosemide	Furosemide	204	94
Metoprolol Succinate	Metoprolol Succinate	200	81
Albuterol Sulfate Hfa	Albuterol Sulfate	161	71
Eliquis	Apixaban	161	64
Omeprazole	Omeprazole	153	67
Losartan Potassium	Losartan Potassium	149	67
Lisinopril	Lisinopril	148	61
Simvastatin	Simvastatin	147	50
Donepezil Hcl	Donepezil Hcl	124	49
Pantoprazole Sodium	Pantoprazole Sodium	123	47
Metoprolol Tartrate	Metoprolol Tartrate	116	39
Tamsulosin Hcl	Tamsulosin Hcl	112	48
Famotidine	Famotidine	104	48
Quetiapine Fumarate	Quetiapine Fumarate	102	45
Ciprofloxacin Hcl	Ciprofloxacin Hcl	97	90
Hydrochlorothiazide	Hydrochlorothiazide	95	48
Lokelma	Sodium Zirconium Cyclosilicate	86	60
Nifedipine Er	Nifedipine	81	33
Sertraline Hcl	Sertraline Hcl	81	37
Levetiracetam	Levetiracetam	80	30
Trazodone Hcl	Trazodone Hcl	77	38
Rosuvastatin Calcium	Rosuvastatin Calcium	76	39
Ammonium Lactate	Ammonium Lactate	74	43
Glipizide	Glipizide	74	24
Hydralazine Hcl	Hydralazine Hcl	73	29
Memantine Hcl	Memantine Hcl	71	40
Latanoprost	Latanoprost	65	24
Levofloxacin	Levofloxacin	65	63
Alprazolam	Alprazolam	63	20
Diclofenac Sodium	Diclofenac Sodium	63	26
Januvia	Sitagliptin Phosphate	60	22
Montelukast Sodium	Montelukast Sodium	59	30
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	57	19
Risperidone	Risperidone	57	17
Escitalopram Oxalate	Escitalopram Oxalate	55	21
Mirtazapine	Mirtazapine	55	28
Carvedilol	Carvedilol	54	31
Clopidogrel	Clopidogrel Bisulfate	54	27
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	53	30
Nystatin	Nystatin	53	28
Meclizine Hcl	Meclizine Hcl	52	18
Tramadol Hcl	Tramadol Hcl	50	19
Zolpidem Tartrate	Zolpidem Tartrate	47	29
Duloxetine Hcl	Duloxetine Hcl	46	18
Silver Sulfadiazine	Silver Sulfadiazine	45	21
Labetalol Hcl	Labetalol Hcl	39	suppressed
Loperamide	Loperamide Hcl	39	suppressed
Tradjenta	Linagliptin	39	12
Potassium Chloride	Potassium Chloride	37	22
Lorazepam	Lorazepam	36	15
Spironolactone	Spironolactone	36	17
Enalapril Maleate	Enalapril Maleate	35	17
Fluticasone Propionate	Fluticasone Propionate	35	17
Olanzapine	Olanzapine	35	suppressed
Jardiance	Empagliflozin	34	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	14
Meloxicam	Meloxicam	33	19
Carbidopa-Levodopa	Carbidopa/Levodopa	32	12
Clonazepam	Clonazepam	31	18
Novolog Flexpen	Insulin Aspart	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	12
Ssd	Silver Sulfadiazine	31	15
Entresto	Sacubitril/Valsartan	30	17
Allopurinol	Allopurinol	29	suppressed
Azithromycin	Azithromycin	29	27
Celecoxib	Celecoxib	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Finasteride	Finasteride	29	18
Alendronate Sodium	Alendronate Sodium	28	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	12
Baclofen	Baclofen	26	15
Mupirocin	Mupirocin	25	19
Linzess	Linaclotide	23	suppressed
Ozempic	Semaglutide	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Ibuprofen	Ibuprofen	22	12
Divalproex Sodium	Divalproex Sodium	21	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Atenolol	Atenolol	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Xarelto	Rivaroxaban	20	11
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Vascepa	Icosapent Ethyl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	15
Timolol Maleate	Timolol Maleate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Cefpodoxime Proxetil	Cefpodoxime Proxetil	16	16
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Prednisone	Prednisone	16	14
Dorzolamide Hcl	Dorzolamide Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lactulose	Lactulose	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	14
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Restasis	Cyclosporine	15	suppressed
Methimazole	Methimazole	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Acetazolamide Er	Acetazolamide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Nyamyc	Nystatin	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Torsemide	Torsemide	13	suppressed
Folic Acid	Folic Acid	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Clonidine	Clonidine	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error